Sema 10mg*10vials

▎Sema Structure

▎Sema Research

What is Sema?

Sema is a synthetic peptide compound and belongs to a type of nootropic. Its main component is an analog of thyrotropin-releasing hormone (TRH), combined with other amino acids (such as valine and leucine). Sema can improve cognitive functions by regulating neurotransmitters (such as dopamine and norepinephrine) in the central nervous system, including enhancing memory, improving attention, and learning ability.

What is the research background of Sema?

Development based on ACTH fragments: 

Sema is composed of the ACTH (4 - 7) fragment and the tripeptide Pro - Gly - Pro (PGP). ACTH, namely adrenocorticotropic hormone, is a hormone secreted by the anterior pituitary gland and plays an important role in regulating the function of the adrenal cortex. Researchers analyzed the structure of ACTH, extracted a specific fragment (4 - 7) from it, and combined it with the tripeptide PGP to synthesize Sema. This synthesis method enables Sema to retain part of the activity of ACTH and also have unique biological characteristics ^[1].

Exploration of epilepsy treatment: 

Epilepsy is a disorder of brain function characterized by abnormal depolarization of neurons. Seizures are a major symptom of epilepsy, usually caused by brain injury. Although current drugs for treating epilepsy have certain effects, they also have some negative health impacts. In this situation, researchers began to look for new treatment methods. As a neuropeptide, Sema peptide acts directly on the central nervous system and has no hormonal activity, so it will not cause negative health impacts. This provides new possibilities for the treatment of epilepsy ^[2].

Treatment of ischemic stroke: 

Ischemic stroke is a serious disease, and due to its high incidence and high disability rate, it has always been a focus of medical research. Sema peptide, due to its neuroprotective and immunomodulatory effects, is applied to the treatment of ischemic stroke. Studies have shown that Sema can inhibit the expression of inflammatory genes and activate the expression of neurotransmitter genes, thus exerting neuroprotective effects at the transcriptional and protein levels ^{[3, 4]}.

A new direction for the treatment of depression: 

Selective serotonin reuptake inhibitors (SSRI) are commonly used drugs for the treatment of depression during pregnancy, but SSRIs can cross the placenta and may affect the maturation of the fetal brain. As a synthetic analog of ACTH (4-10), Sema has obvious nootropic and neuroprotective activities. Research has found that Sema can reduce the behavioral and neurochemical changes in rats caused by early exposure to fluvoxamine, providing a new idea for the treatment of depression^[5].

Advantages of peptide substances: 

Sema is a synthetic peptide substance with a unique mechanism of action. It can act directly on the central nervous system, synthesize some proteins in the brain, and exert antioxidant effects. For example, in a rat model of epilepsy, Sema peptide can reduce the MDA level and synthesize three proteins that are not synthesized in epileptic rats^[2].

As a regulatory peptide, the research history of Sema can be traced back a long time ago. Studies have shown that Sema has application prospects in memory disorders, decreased efficiency of mental work, and post-COVID syndrome, in addition to somatoform and psychosomatic diseases^[6].

Analysis of changes in the level of the pJNK and pCREB proteins during ischemia and Sema treatment in the subcortical structures and frontoparietal cortex of rats at 24 h after tMCAO.

Source:PubMed^[4]

How does the mechanism of action of Sema in treating epilepsy specifically affect brain function?

Antioxidant effect

Sema has antioxidant properties. Epilepsy usually leads to an increase in oxidative stress in the brain, and Sema can reduce the damage to the brain caused by oxidative stress. Oxidative stress will produce excessive reactive oxygen species, such as malondialdehyde (MDA). Studies have shown that Sema can reduce the MDA level in the brains of epileptic rats by up to 40.46%^[2]. By reducing the MDA level, Sema can alleviate the damage of oxidative stress to neurons, thus protecting brain function.

Synthesis of brain proteins

Sema can synthesize some proteins in the brain. In the study of epileptic rats, after treatment with Sema, three proteins that were not synthesized in epileptic rats were synthesized. The molecular weights of these proteins are 93.54kDa, 66.76kDa, and 59.66kDa^[2]. They can play important roles in maintaining the normal function of the brain and repairing damaged neurons.

Influence on the brain neuron network

Through resting-state functional magnetic resonance imaging (resting-state FMRI) studies, it has been found that Sema has an impact on the brain neuron network. In the study of healthy volunteers, compared with the control group, a larger volume of the rostral (intermediate anterior cortex) sub-component of the default mode network was detected in the Sema group^[7]. This indicates that Sema may improve brain function by regulating the connections and activities of the brain neuron network.

When Sema was injected daily into audiogenic seizure-prone rats from the 7th to the 11th day of life, it was found that the audiogenic seizure pattern of the rats changed when they were 1 month old, and both drugs could enhance neurogenesis in the hippocampal dentate gyrus. Neurogenesis may be related to the learning, memory, and repair functions of the brain, and Sema may improve brain function by promoting neurogenesis.

When Sema was injected into five inbred mouse strains of newborns (from the 2nd to the 7th day of life), it significantly reduced the susceptibility to convulsions only in 1-month-old DBA / 2J mice^[8]. This also indicates that Sema may affect brain function through some mechanism and reduce the susceptibility to epilepsy.

Lack of hormonal activity

Sema is a neuropeptide that acts directly on the central nervous system and has no hormonal activity, so it will not cause negative health effects (Puspita R, 2018). This gives Sema certain advantages in the treatment of epilepsy, avoiding the possible side effects of traditional antiepileptic drugs.

What is the specific mechanism by which Sema regulates immune function?

Enhancing immune response-related signaling pathways: 

Sema can enhance the antigen presentation signaling pathway. Antigen presentation is a key process for the immune system to recognize and process foreign antigens. By enhancing this signaling pathway, Sema can promote the recognition and response of the immune system to foreign substances such as pathogens^[1]. In addition, Sema can also strengthen the impact of ischemia on the interferon signaling pathway. Interferon plays an important regulatory role in the immune response, including antiviral, antitumor, and regulating the activity of immune cells. The strengthening of the interferon signaling pathway by Sema helps to improve the overall activity of the immune system^[1].

Influencing the immunoglobulin synthesis process: 

Sema significantly increases the expression of genes encoding the heavy chains of immunoglobulins. Immunoglobulins play a key role in humoral immunity and can specifically bind to antigens, thus eliminating foreign substances such as pathogens. Sema promotes the synthesis of immunoglobulins, which helps to enhance the humoral immune function of the body ^[1].

Regulating the activity of immune cells: 

Sema has a great influence on genes encoding cytokines, stress responses, and ribosomal proteins. Cytokines play an important role in immunomodulation and can regulate the proliferation, differentiation, and activity of immune cells. Sema regulates the activity of immune cells by influencing the expression of these genes, thereby regulating immune function^[1].

What are the applications of Seamx?

Treatment of epilepsy

Influence on neurons: 

Epilepsy is a disorder of brain function characterized by abnormal depolarization of neurons. Sema peptide is a neuropeptide that acts directly on the central nervous system and does not contain hormonal activity, so it will not have a negative impact on health. Sema can reduce the MDA level in the brains of epileptic rats. MDA is an indicator of lipid peroxidation, and high levels of MDA are associated with oxidative stress and cell damage. Sema can reduce the MDA level in the brains of epileptic rats by up to 40.46% ^[9].

Synthesis of proteins: 

Sema can also synthesize some proteins in the brains of epileptic rats. Studies have found that Sema can synthesize three proteins that were not originally synthesized in the brains of epileptic rats, and the molecular weights of these proteins are 93.54 kDa, 66.76 kDa, and 59.66 kDa respectively^[9].

Treatment of ischemic stroke

Enhancing neurotrophin transcription: 

Sema (MET-GLU - amino acid - phenylalanine - proline - glycine - proline) peptide is a synthetic melanocortin derivative used for the treatment of ischemic stroke. Studies have shown that Sema can enhance the transcription of neurotrophins and their receptors and modulate the expression of genes involved in the immune response. Whole-genome RNA sequencing analysis shows that in the transient middle cerebral artery occlusion (tMCAO) model in rats, Sema inhibits the expression of inflammatory genes and activates the expression of neurotransmitter genes^[4].

Regulating the expression of key proteins: 

24 hours after tMCAO, an upregulation of active CREB was observed in subcortical structures, including the focus of ischemic injury; MMP - 9 and c - fos were downregulated in the adjacent frontoparietal cortex; under the action of Sema, active JNK was also downregulated in these two tissues. The inhibition and recovery of activation in the processes of inflammation and cell death may contribute to the neuroprotective effect of Sema at the transcriptional and protein levels ^[4].

Relieving acute stress

Reducing pain: 

In an acute stress model, Sema has a certain impact on the behavior and pain sensitivity of rats. In the inescapable intermittent foot shock stress and forced cold water swimming stress models, both Sema and the opioid receptor antagonist naloxone can attenuate the stress-induced analgesia (SIA) in the inescapable foot shock stress model, but do not affect the pain threshold in the forced cold water swimming stress model^[10].

No impact on behavioral changes: 

Both Sema and naloxone do not affect the behavior of rats in the above acute stress models^[10].

Improving memory and attention: 

Sema can stimulate the working memory and attention of experimental animals and humans, increase resistance to hypoxia, and improve cerebral blood circulation. Sema significantly improves the memory and attention of healthy people under extreme activity conditions. In addition, Sema has currently been successfully used to treat patients with different diseases of the central nervous system. In most cases, this peptide shows positive effects without producing negative side effects or complications related to administration^[11].

In conclusion, as a synthetic peptide compound, Sema shows significant curative effects in the fields of epilepsy, ischemic stroke, acute stress, and cognitive impairment through multiple mechanisms such as regulating the expression of neurotrophins (such as BDNF) and their receptors (TrkB), inhibiting the inflammatory response, resisting oxidative stress, and immunomodulation. It can also improve the recovery of nerve function, reduce brain damage, and enhance memory and attention.

About The Author

The above-mentioned materials are all researched, edited and compiled by Cocer Peptides.

Scientific Journal Author

Sudarkina O Y is a researcher affiliated with the National Research Centre - Kurchatov Institute and the Russian Academy of Sciences. Her research interests span multiple scientific disciplines, including Biochemistry & Molecular Biology, Genetics & Heredity, and Chemistry. She has made significant contributions to the fields of Biotechnology, Molecular Breeding, and Molecular Plant Pathology. Her work involves the study of genetic mechanisms, molecular interactions, and biochemical processes that underpin various biological phenomena. Through her research, she aims to advance our understanding of these complex systems and develop innovative solutions for practical applications in agriculture, medicine, and other industries. Sudarkina O Y is listed in the reference of citation [4].

▎Relevant Citations

[1] Medvedeva E V, Dmitrieva V G, Limborska S A, et al. Sema, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats[J]. Molecular Genetics and Genomics, 2017,292(3):635-653.DOI:10.1007/s00438-017-1297-1.

[2] Puspita R, Pratamastuti D, Safitri A, et al. The Potency of Sema Peptide Therapy toward MDA Level and Protein Profile in Epilepsy Rats (Rattus norvegicus), 2018[C]. https://api.semanticscholar.org/CorpusID:90160574

[3] Dergunova L V, Dmitrieva V G, Filippenkov I B, et al. The Peptide Drug ACTH(4-7)PGP (Sema) Suppresses mRNA Transcripts Encoding Proinflammatory Mediators Induced by Reversible Ischemia of the Rat Brain[J]. Molecular Biology, 2021,55(3):346-353.DOI:10.1134/S0026893321010040.

[4] Sudarkina O Y, Filippenkov I B, Stavchansky V V, et al. Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Sema) in a Rat Model of Cerebral Ischemia-Reperfusion[J]. International Journal of Molecular Sciences, 2021,22(12).DOI:10.3390/ijms22126179.

[5] Glazova N Y, Manchenko D M, Volodina M A, et al. Sema, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats[J]. Neuropeptides, 2021,86.DOI:10.1016/j.npep.2020.102114.

[6] Hadarceva K, Belyaeva E. Sema-application prospect (brief overview message).[J]. Clinical Medicine and Pharmacology, 2021.DOI:https://api.semanticscholar.org/CorpusID:245468513.

[7] Lebedeva I S, Panikratova Y R, Sokolov O Y, et al. Effects of Sema on the Default Mode Network of the Brain[J]. Bulletin of Experimental Biology and Medicine, 2018,165(5):653-656.DOI:10.1007/s10517-018-4234-3.

[8] Boyarshinova O S, Perepelkina O V, Markina N V, et al. Audiogenic Epilepsy in Young Mice of Different Strains after Neonatal Sema Treatment[J]. Bulletin of Experimental Biology and Medicine, 2008,146(1):86-88.DOI:10.1007/s10517-008-0212-5.

[9] Puspita R. Sema for Epilepsy Treatment[M]. 2020.DOI:10.31219/osf.io/hcn3g.

[10] Glazova N Y, Manchenko D M, Vilensky D A, et al. Effects of Sema in the Rat Models of Acute Stress[J]. Journal of Evolutionary Biochemistry and Physiology, 2023,59(1):200-212.DOI:10.1134/S0022093023010179.

[11] Ashmarin I P, Nezavibatko V N, Myasoedov N F, et al. Nootropic analogue of adrenocorticotropin 4-10-semax (the experience of design and investigation over 15 years)[J]. Zhurnal Vysshei Nervnoi Deyatelnosti Imeni I P Pavlova, 1997,47(2):420-430. https://pubmed.ncbi.nlm.nih.gov/9173745/

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE SOLELY FOR INFORMATION DISSEMINATION AND EDUCATIONAL PURPOSES.  

The products provided on this website are intended exclusively for in vitro research. In vitro research (Latin: *in glass*, meaning in glassware) is conducted outside the human body. These products are not pharmaceuticals, have not been approved by the U.S. Food and Drug Administration (FDA), and must not be used to prevent, treat, or cure any medical condition, disease, or ailment. It is strictly prohibited by law to introduce these products into the human or animal body in any form.